Upon co-delivery of gefitinib and CQ in mAb MDR1-NPs, more NPs were transported into those cancer cells expressing MDR1 at high levels due to the interaction between mAb MDR1 and its receptors. This evidence concerns the gene ABCB1 and cancer.